Participation in a novel treatment component during residential substance use treatment is associated with improved outcome: a pilot study

Table 3 Treatment completion by co-morbid Axis I Disorder

	RRTP-CP		NR-Horticulture			NR-Art/Music
	Total Participants (n)	Completed Treatment %	Total Participants (n)	Completed Treatment %	p-value	Total Participants (n)	Completed Treatment %	p-value
Substance-Induced Disorders	12	75	0	n/a	n/a	0	n/a	n/a
Dementia, Cognitive Disorder	3	100	0	n/a	n/a	0	n/a	n/a
Schizophrenia, Schizoaffective	15	60	3	100	0.00	3	100	0.18
Major Depression	37	68	16	81	0.31	3	100	0.24
Bipolar I, II	31	58	9	67	0.64	5	80	0.35
Bipolar NOS & Mood Disorder NOS	23	61	3	67	0.36	4	100	0.13
Malingering	3	100	2	100	n/a	1	100
Anxiety Disorders	14	64	4	75	0.69	1	100	0.47
Dysthymic Disorder	21	52	3	67	0.54	1	100	0.35
Depression NOS	102	71	17	81	0.00	9	55	0.35
Attention Deficit Disorder	4	50	4	100	0.10	1	100	0.36
Adjustment Disorder	7	29	2	100	0.07	0	n/a	n/a
All Other Axis I Diagnoses	5	60	0	n/a	n/a	0	n/a	n/a
Total with co-morbid disorders	277	65	63	79	0.02	25	72	0.49
Total with no co-morbid disorder	235	80	37	87	0.35	5	80	1.00

ISSN: 1940-0640